DE69836197D1 - Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren - Google Patents

Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren

Info

Publication number
DE69836197D1
DE69836197D1 DE69836197T DE69836197T DE69836197D1 DE 69836197 D1 DE69836197 D1 DE 69836197D1 DE 69836197 T DE69836197 T DE 69836197T DE 69836197 T DE69836197 T DE 69836197T DE 69836197 D1 DE69836197 D1 DE 69836197D1
Authority
DE
Germany
Prior art keywords
antibodies
systemic lupus
sera
smd
methylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69836197T
Other languages
English (en)
Other versions
DE69836197T2 (de
Inventor
Lydie Meheus
Georg Luehrmann
Ann Union
Joseph Raymackers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of DE69836197D1 publication Critical patent/DE69836197D1/de
Publication of DE69836197T2 publication Critical patent/DE69836197T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
DE69836197T 1997-08-29 1998-08-31 Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren Expired - Lifetime DE69836197T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97870127 1997-08-29
EP97870127 1997-08-29
PCT/EP1998/005518 WO1999011667A1 (en) 1997-08-29 1998-08-31 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Publications (2)

Publication Number Publication Date
DE69836197D1 true DE69836197D1 (de) 2006-11-30
DE69836197T2 DE69836197T2 (de) 2007-09-06

Family

ID=8231033

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836197T Expired - Lifetime DE69836197T2 (de) 1997-08-29 1998-08-31 Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren

Country Status (9)

Country Link
US (2) US6362007B1 (de)
EP (1) EP0944649B1 (de)
JP (1) JP2001505785A (de)
AT (1) ATE342920T1 (de)
AU (1) AU751784B2 (de)
CA (1) CA2270176C (de)
DE (1) DE69836197T2 (de)
ES (1) ES2276474T3 (de)
WO (1) WO1999011667A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020002270A1 (en) * 1999-06-16 2002-01-03 Raymond P. Zinkowski Purified antigen for alzheimer's disease, and methods of obtaining and using same
US6699673B2 (en) 1999-12-22 2004-03-02 The Research Foundation Of State University Of New York Protein methylarginine-specific antibodies
EP1162274A1 (de) * 2000-06-09 2001-12-12 Boehringer Ingelheim International GmbH Verfahren zur Identifizierung von Verbindungen, die die Methyltransferase-abhängige Chromosomen-Stabilität beeinflussen
EP1294927B1 (de) * 2000-06-09 2005-11-16 Boehringer Ingelheim International GmbH Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität
EP1162460A1 (de) * 2000-06-09 2001-12-12 Boehringer Ingelheim International GmbH Screeningverfahren für Modulatoren des Suv39h2 Methyltransferases und der männlichen Gametogenese
US7332168B2 (en) 2000-08-22 2008-02-19 Micromet Ag Composition for the elimination of autoreactive B-cells
SE0300958D0 (sv) * 2003-04-02 2003-04-02 Pharmacia Diagnostics Ab Analytical method and kit therof
WO2005075414A1 (ja) * 2004-02-04 2005-08-18 Yokohama City University ぺプチジルアルギニンデイミナーゼ4阻害剤
US20050277205A1 (en) * 2004-02-20 2005-12-15 Ki-Bum Lee Multicomponent magnetic nanorods for biomolecular separations
US7422696B2 (en) * 2004-02-20 2008-09-09 Northwestern University Multicomponent nanorods
WO2010005718A1 (en) * 2008-06-16 2010-01-14 University Of Louisville Research Foundation, Inc Systems and methods for diagnosis and prognosis of cancer
CA2904960A1 (en) 2013-03-14 2014-10-02 University Of Florida Research Foundation, Inc. Di-amino acid repeat-containing proteins associated with als
JP2019515894A (ja) 2016-04-04 2019-06-13 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 反復関連非atg(ran)翻訳を調節するためのeif3の操作
CN106188272A (zh) * 2016-07-27 2016-12-07 朱玫玫 基因工程鼠提高Btg2表达水平的新功能
AU2018255293B2 (en) 2017-04-17 2024-03-07 University Of Florida Research Foundation, Incorporated Regulation of RAN translation by PKR and eIF2a-P pathways
WO2019067587A1 (en) 2017-09-26 2019-04-04 University Of Florida Research Foundation, Incorporated USE OF METFORMIN AND ANALOGUES THEREOF TO REDUCE RAN PROTEIN RATES DURING TREATMENT OF NEUROLOGICAL DISORDERS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
FR2663034B1 (fr) 1990-06-06 1995-04-21 Neosystem Sa Peptides de l'antigene sm-d et leur utilisation notamment pour le diagnostic du lupus erythemateux dissemine.
JPH09508891A (ja) 1993-11-17 1997-09-09 デューク ユニバーシティ メディカル センター 自己免疫疾患の治療におけるナイトリックオキサイドシンターゼ阻害剤の使用
EP0776906A3 (de) * 1995-10-19 1998-02-25 Imtec Immundiagnostika Gmbh Peptide des Antigens Sm-D und ihre Verwendung, insbesondere für die Diagnostik des SLE

Also Published As

Publication number Publication date
ES2276474T3 (es) 2007-06-16
DE69836197T2 (de) 2007-09-06
CA2270176C (en) 2011-08-23
EP0944649A1 (de) 1999-09-29
US6362007B1 (en) 2002-03-26
JP2001505785A (ja) 2001-05-08
EP0944649B1 (de) 2006-10-18
CA2270176A1 (en) 1999-03-11
AU751784B2 (en) 2002-08-29
AU9438798A (en) 1999-03-22
WO1999011667A1 (en) 1999-03-11
US20020165355A1 (en) 2002-11-07
ATE342920T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DE69836197D1 (de) Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
EP2258383A3 (de) Von der Telomerase abgeleitete antigene Peptide
ATE267211T1 (de) Impfstoff gegen hpv
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
MXPA02005576A (es) Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
EP1200124A4 (de) Immunglobulin fusionsproteine
DE69609188D1 (de) Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
ATE326479T1 (de) Varianten von antigenen des menschlichen papillomvirus
DE602004009705D1 (de) Methoden der Verhinderung und Behandlung der Alzheimer'schen Krankheit
EP0269455A3 (de) Hochgereinigtes Fusionsprotein, das ein menschliches IgE Fc-Fragment enthält, sowie dessen Herstellung
DE69508382D1 (de) Peptomere mit erhöhter immunogenizität
AU2105888A (en) Synthetic peptides, antibodies directed against them, and the use thereof
ATE248601T1 (de) Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
DE69330268D1 (de) Hämoregulierende peptide
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
DE69329347T2 (de) Immunreaktive peptide des epstein-barrvirus
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
NZ508812A (en) Peptides for the prevention or treatment of HIV
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition